STEM-11. A MAPK-DRIVEN miR-124-SOX9 AXIS IS CRITICAL FOR STEM CELL MAINTENANCE, PROGRESSION, AND THERAPY-RESISTANCE IN GLIOBLASTOMA
Hanna Sabelström(University of California, San Francisco), Anders I. Persson(University of California, San Francisco), Mitchel S. Berger(University of California, San Francisco), Rebecca Petri(Lund University), Johan Jakobsson(Lund University), Edith Yuan(University of California, San Francisco), Ksenya Shchors(Cancer Research Institute), Rohit Sacheva(Lund University), William A. Weiss(City College of San Francisco), Selma Masic(UCSF Helen Diller Family Comprehensive Cancer Center), Evan Snyder(Sanford Burnham Prebys Medical Discovery Institute), Theo Nicolaides(St. Jude Children's Research Hospital), Trenten Fenster(University of California, San Francisco), Rahul Jandial(City Of Hope National Medical Center), Shirin IIkhanizadeh(University of California, San Francisco)
Cited by 0
Related Papers
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
A Pharmacological Map of the PI3-K Family Defines a Role for p110α in Insulin Signaling
|Cell|2006|1.2k
Impact of Intraoperative Stimulation Brain Mapping on Glioma Surgery Outcome: A Meta-Analysis
|Journal of Clinical Oncology|2012|1k
miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells
|BMC Medicine|2008|948
Targeted expression of MYCN causes neuroblastoma in transgenic mice
|The EMBO Journal|1997|870